Funder: Food and Drug Administration
Due Dates: Forecasted for FY2025 | Estimated due date not yet posted
Funding Amounts: Award ceiling: $900,000 | Award floor: $650,000 | Single-year R01 clinical trial support
Summary: Supports clinical trials evaluating new treatments or labeling changes for rare neurodegenerative diseases in adults and children to increase FDA-approved therapies.
Key Information: This is a forecasted opportunity; application details and deadlines are forthcoming.